Scientists test 'Off-the-Shelf' cell therapy to wipe out leukemia before transplant
NCT ID NCT05942599
Summary
This early-stage trial is testing a new, 'ready-made' cell therapy called BE CAR-33 in children whose acute myeloid leukemia (AML) has returned. The therapy uses healthy donor immune cells that are genetically edited to find and kill leukemia cells. The main goal is to see if this treatment is safe and can clear the cancer to prepare children for a planned bone marrow transplant, which aims to keep the cancer from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED ACUTE MYELOID LEUKAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Great Ormond Street Hospital for Children
London, WC1N3JH, United Kingdom
Conditions
Explore the condition pages connected to this study.